Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration. [electronic resource]
Producer: 20150820Description: 112-7 p. digitalISSN:- 1744-5205
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Choroidal Neovascularization -- diagnosis
- Combined Modality Therapy
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Photochemotherapy -- methods
- Photosensitizing Agents -- therapeutic use
- Porphyrins -- therapeutic use
- Prospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Verteporfin
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.